How to Invest in This Growing Pharmaceutical Company

1 Mins read

Last week, Danish pharmaceutical company Novo Nordisk announced its first quarter earnings beating estimates, raising its growth outlook for the rest of 2022 and expanding its buyback program, reports Reuters.

Novo Nordisk’s first quarter operating profit was 19 billion Danish crowns (approximately $2.69 billion), well above the estimated 17 billion Danish crowns. The company has also lifted its sales estimates 10%-14% in local currency, a gain from the previous estimates of 6%-10% for the remainder of the year, with production estimates also growing.

“We are very pleased with the sales growth in the first three months of 2022 which is driven by increasing demand for our GLP-1-based treatments,” CEO Lars Jorgensen said in a statement, referring to the company’s newer line of diabetes and obesity drugs.

The company has also announced that it will expand its buyback program by another 2 billion Danish crowns to a total of 24 billion crowns.

The newest obesity drug, Wegovy, is expected to help drive some of that growth as commercial production resumes after being halted in December; the drug should be fully available within the U.S. in the second half of 2022 and is highly anticipated.

Another main drug, Ozempic, used to treat diabetes, has contributed to recent growth, making up 12 billion in sales in local currency in Q1, a 70% growth. Demand is so great that the company has factored in some supply constraints into its newest estimates, which shouldn’t impact the growth of the business overall.

“We have seen some (supply issues), but none of them something that is material to Novo Nordisk,” Jorgensen said to journalists on a call

Related posts
InvestmentsMotor / Cars / MarineNews

Hyundai to invest $5.5 billion to build EVs and batteries in Georgia

1 Mins read
KEY POINTS Hyundai Motor on Friday confirmed plans to spend $5.54 billion to build its first dedicated electric vehicle and battery manufacturing…
Crypto CurrencyInvestments

Bill Gates said he doesn't own any cryptocurrency because it isn't 'adding to society'

1 Mins read
Bill Gates said he doesn’t invest in cryptocurrency because he likes investing in things with “valuable output.” Gates has cautioned people against…

South African fintech JUMO raises $120m to drive its expansion into Nigeria

2 Mins read
JUMO, a South Africa and London-based company that offers financial services in form of credit to entrepreneurs and businesses, has raised $120…

Leave a Reply

Your email address will not be published.